↓
 

ParagraphFour.com

Pharmaceutical Patent Database

ParagraphFour.com
  • Home
  • About
  • Paragraph IV Explained
  • FAQ & Terms
  • The PIV Book
  • The PIV Blog
  • PIV Data
    • Get Access
Home→parryashford

parryashford

Profile picture of parryashford

@parryashford

Active 1 day, 3 hours ago
  • Activity
  • Profile
  • Forums
  • View

View Profile

Base

Name

parryashford

Login

Log In

Latest updates

Ingrezza®(valbenazine) Capsules
Annual Sales $993M
Company NEUROCRINE
Date of First Filing April 12, 2021

Paragraph IV Applicant: Lupin
Case Name: NEUROCRINE BIOSCIENCES INC v. LUPIN LIMITED et al
Court/Case #: Delaware District Court (dedc) 1:2021cv01042
Date Filed: 7/16/21
Judge:
Product Strength: 40 mg and 80 mg
Litigated…Read more

Profile picture of parryashford 1 week ago

Tymlos®(abaloparatide) Injection
Annual Sales
Company ELI LILLY
Date of First Filing Not applicable

Paragraph IV Applicant: Radius Health
Case Name: ELI LILY AND COMPANY v. RADIUS HEALTH INC
Court/Case #: Delaware District Court (dedc) 1:2021cv01003
Date Filed: 7/8/21
Judge: Connolly
Product Strength: 3.12mg/1.56mL (2mg/mL);…Read more

Profile picture of parryashford 2 weeks, 3 days ago

Austedo®(deutetrabenazine) Tablets
Annual Sales $134M
Company TEVA
Date of First Filing April 5, 2021

Paragraph IV Applicant: Aurobindo
Case Name: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC et al AUROBINDO PHARMA LTD et al
Court/Case #: New Jersey District Court (njdc) 3:2021cv13240
Date Filed: 7/1/21
Judge: Wolfson
Product…Read more

Profile picture of parryashford 3 weeks ago
The Paragraph Four Report®, ParagraphFour.com® and the PFOUR logo are registered trademarks of Parry Ashford Inc. • ©Parry Ashford Inc. 2021
↑